CLINICAL PHARMACY CONGRESS IS SPONSORED BY THE PHARMACEUTICAL AND MED TECH INDUSTRIES VIA GRANTS, SPONSORSHIP, AND EXHIBITION PACKAGES. PHARMACEUTICAL COMPANIES HAVE SOLELY PROVIDED SPONSORSHIP THROUGH THE PURCHASE OF EXHIBITION SPACE AND/OR SPONSORED SPEAKER SESSIONS WITH NO FURTHER INPUT INTO THE ARRANGEMENTS OR AGENDA OF THE MEETING. SESSIONS DELIVERED WITH INPUT FROM OUR SPONSORS WILL ALWAYS BE MARKED ON THE PROGRAMME. A FULL LIST OF CONFIRMED SPONSORS FOR CLINICAL PHARMACY CONGRESS LONDON IS AVAILABLE HERE.

7-8 MAY 2027
EXCEL, LONDON

CPC 2026 Content Programme

Subpage Hero

.

Loading

From evidence to action: optimising metabolic dysfunction-associated steatotic liver disease (MASLD) management in pharmacy practice

08 May 2026

13:15 - 14:00

Technical Services Theatre

From evidence to action: optimising metabolic dysfunction-associated steatotic liver disease (MASLD) management in pharmacy practice

Approximately 1 in 5 patients in the UK are currently living with metabolic-dysfunction associated liver disease (MASLD). This presentation will equip pharmacy professionals with the knowledge to identify and manage MASLD in primary and secondary care.

* Describe the risk factors for MASLD
* Understand the pharmacological and non-pharmacological management of MASLD and barriers for treatment
* Become familiar with treatments on the horizon

Chairperson

Kieran Reynolds, Advanced Specialist Pharmacist - Medicines Governance, Medicines Use and Safety - NHS Specialist Pharmacy Service

Speakers

Leslie Wong, Advanced Clinical Pharmacist – Hepatology and the Eastern Liver Network - Cambridge University Hospitals NHS Foundation Trust

Aimee Francisco, Advanced Specialist Pharmacist – Gastroenterology - Gloucestershire Hospitals NHS Foundation Trust